https://cytoskeletalsignaling.....com/index.php/influe
The goal of this study was to evaluate the effects of leukapheresis in APL, specifically for effectiveness and safety. /L before induction chemotherapy. Thirty-nine customers were initially treated with leukapheresis, whereas one other 46 are not. Medical and laboratory variables between these teams had been compared. There was clearly a trend toward favorable 30-day success price for the leukapheresis team weighed against the non-leukapheresis team (76.9% and 67.4%; P=0.24). The
Like
Comment
Share
